Zhengye Biotechnology regains Nasdaq compliance with $1 minimum bid price rule
ZYBT•Nasdaq compliance regained
Zhengye Biotechnology regained compliance with Nasdaq’s $1 minimum bid-price rule, removing the risk of a delisting process tied to the deficiency.
Nasdaq confirmed the shares closed at $1 or higher for 10 consecutive sessions from July 20 to Aug. 4, following a May 29 notice.
